SALIZZATO, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 1.102
EU - Europa 213
AS - Asia 137
AF - Africa 1
OC - Oceania 1
Totale 1.454
Nazione #
US - Stati Uniti d'America 1.102
CN - Cina 114
IT - Italia 112
SE - Svezia 42
FI - Finlandia 22
DE - Germania 12
VN - Vietnam 11
IN - India 8
FR - Francia 6
UA - Ucraina 6
GB - Regno Unito 4
IE - Irlanda 4
KR - Corea 4
BE - Belgio 2
NL - Olanda 2
EG - Egitto 1
NZ - Nuova Zelanda 1
PL - Polonia 1
Totale 1.454
Città #
Fairfield 174
Woodbridge 127
Chandler 116
Ashburn 89
Ann Arbor 79
Seattle 79
Wilmington 76
Houston 64
Cambridge 62
Padova 48
Beijing 28
Des Moines 28
New York 16
Princeton 16
Nanjing 15
Medford 14
Jacksonville 13
Boardman 12
Cagliari 12
Helsinki 12
Dong Ket 11
Nanchang 7
San Diego 7
Shenyang 7
Falls Church 6
Jinan 6
Tianjin 6
Arezzo 5
Changsha 5
Verona 5
Dublin 4
Los Angeles 4
Milan 4
Ningbo 4
Roxbury 4
Vicenza 4
Bupyeong-gu 3
Gazzo 3
Guangzhou 3
Ogden 3
Redwood City 3
Albignasego 2
Argenteuil 2
Brussels 2
Campodarsego 2
Chengdu 2
Haikou 2
Hangzhou 2
Hebei 2
Hefei 2
Kharkiv 2
Norwalk 2
Paris 2
Pasiano 2
San Giovanni La Punta 2
Sherman Oaks 2
Taizhou 2
Tappahannock 2
Xian 2
Auburn Hills 1
Bari 1
Cairo 1
Cheonan 1
Chiswick 1
Chongqing 1
Christchurch 1
Corpus Christi 1
Florence 1
Frankfurt am Main 1
Fuzhou 1
Hanover 1
Kunming 1
Lanzhou 1
Las Vegas 1
Mariano Comense 1
Mestrino 1
Munich 1
Pune 1
San Francisco 1
San Paolo Solbrito 1
Sant'elena 1
Shanghai 1
Taiyuan 1
Venezia 1
Venice 1
Warsaw 1
Washington 1
Whittier 1
Zhengzhou 1
Totale 1.250
Nome #
CK2 modulates adipocyte insulin-signaling and is up-regulated in human obesity 189
Protein kinase CK2 potentiates translation efficiency by phosphorylating eIF3j at Ser127. 156
A journey through the cytoskeleton with protein kinase CK2 145
Protein kinase CK2 subunits exert specific and coordinated functions in skeletal muscle differentiation and fusogenic activity 132
Protein kinase CK2 is involved in adipose tissue insulin signaling and remodeling during obesity and weight loss 126
Aberrant signalling by protein kinase CK2 in imatinib-resistant chronic myeloid leukaemia cells. Biochemical evidence and therapeutic perspectives 116
null 68
Protein kinase CK2: a new target to overcome imatinib-resistance in chronic myeloid leukemia cells 67
null 66
Deciphering the role of protein kinase CK2 in the maturation/stability of F508del-CFTR 61
J-SUBUNIT OF THE EUKARYOTIC INITIATION FACTOR 3 IS A NEW SUBSTRATE OF PROTEIN KINASE CK2 55
Protein kinase CK2: a new target to overcome imatinib-resistance in CML cells 48
HOW PROTEIN KINASE CK2 IS INVOLVED IN IMATINIB-RESISTANT CHRONIC MYELOID LEUKEMIA CELLS? 46
Targeting protein kinase CK2 to overcome imatinib-resitance 37
INVOLVEMENT OF THE PROTEIN KINASE CK2 AND ITS INTERACTOME IN IMATINIB SENSITIVE AND RESISTANT CHRONIC MYELOID LEUKEMIA CELLS 36
Modulation of protein kinases in the regulation of chaperone machinery leading F508-del-CFTR fate - The Proceedings of the 16th Italian Convention of Investigators in Cystic Fibrosis 33
Protein kinase CK2: a new target to overcome imatinib-resistance in chronic myeloid leukemia cells. 32
Circulating cytokines as predictors of response to immune checkpoint inhibitors (ICIs) in patients (pts) with melanoma (Mel) and non–small cell lung cancer (NSCLC) 25
The protein kinase ck2 associates with and phosphorylates the eukaryotic initiation factor 3 20
Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients 11
null 8
Totale 1.477
Categoria #
all - tutte 4.783
article - articoli 3.788
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.571


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201979 0 0 0 0 0 0 0 0 0 12 33 34
2019/2020313 27 13 3 37 30 18 36 35 29 47 30 8
2020/2021259 16 11 19 32 4 11 5 14 27 69 31 20
2021/2022249 2 33 33 29 22 18 6 24 10 4 16 52
2022/2023229 29 29 0 36 24 48 4 7 23 3 14 12
2023/2024173 7 21 22 13 22 24 9 26 17 12 0 0
Totale 1.477